NCT00415142 - An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder | Biotech Hunter

Enrollment

393

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Depressive Disorder

Interventions

DRUG

saredutant (SR48968)

oral administration (capsules)

DRUG

placebo

oral administration (capsules)

DRUG

escitalopram

oral administration (capsules)

Trial Locations (8)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Zagreb

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Bromma

Sanofi-Aventis Administrative Office, Istanbul